|
Ajanta Pharma Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
31701.44 Cr.
|
P/BV
|
8.62
|
Book Value (Rs.)
|
294.36
|
|
52 Week High/Low (Rs.)
|
3485/2111
|
FV/ML
|
2/1
|
P/E(X)
|
34.44
|
|
Bookclosure
|
06/11/2024
|
EPS (Rs.)
|
73.68
|
Div Yield (%)
|
1.10
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| No. of Equity Shares (in Lacs) | 1253.50 | 1259.16 | 1259.15 | 854.16 | 865.32 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 25.07 | 25.27 | 25.27 | 17.17 | 17.39 |
| Total Share Capital | 25.07 | 25.27 | 25.27 | 17.17 | 17.39 |
| | | | | | |
| Reserves and Surplus | 3765.22 | 3536.44 | 3362.38 | 3247.17 | 2978.24 |
| Total Reserves and Surplus | 3765.22 | 3536.44 | 3362.38 | 3247.17 | 2978.24 |
| Employees Stock Options | 0.00 | 5.65 | 0.34 | 0.00 | 0.00 |
| Total Shareholders Funds | 3790.29 | 3567.36 | 3387.99 | 3264.34 | 2995.63 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 0.00 | 0.00 | 1.25 | 1.64 | 1.60 |
| Deferred Tax Liabilities [Net] | 110.52 | 108.50 | 97.72 | 101.87 | 92.17 |
| Other Long Term Liabilities | 37.77 | 27.23 | 28.63 | 21.02 | 22.76 |
| Long Term Provisions | 80.27 | 39.54 | 24.15 | 19.32 | 17.93 |
| Total Non-Current Liabilities | 228.56 | 175.27 | 151.75 | 143.85 | 134.46 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 2.59 | 1.49 | 0.18 | 0.27 | 0.00 |
| Trade Payables | 454.20 | 463.20 | 422.77 | 327.17 | 373.86 |
| Other Current Liabilities | 515.96 | 413.31 | 702.31 | 309.14 | 263.06 |
| Short Term Provisions | 23.35 | 17.76 | 14.02 | 10.81 | 11.71 |
| Total Current Liabilities | 996.10 | 895.76 | 1139.28 | 647.39 | 648.63 |
| | | | | | |
| Total Capital And Liabilities | 5014.95 | 4638.39 | 4679.02 | 4055.58 | 3778.72 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 1715.50 | 1464.53 | 1488.69 | 1502.97 | 1530.32 |
| Intangible Assets | 46.52 | 14.66 | 7.75 | 9.02 | 10.79 |
| Capital Work-In-Progress | 176.27 | 256.45 | 209.47 | 152.86 | 108.19 |
| Fixed Assets | 1938.29 | 1735.64 | 1705.91 | 1664.85 | 1649.30 |
| Non-Current Investments | 25.24 | 18.58 | 25.10 | 25.10 | 0.00 |
| Deferred Tax Assets [Net] | 186.43 | 134.45 | 96.77 | 55.55 | 50.10 |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 6.47 |
| Other Non-Current Assets | 21.96 | 18.80 | 17.24 | 45.62 | 45.26 |
| Total Non-Current Assets | 2171.92 | 1907.47 | 1845.02 | 1791.12 | 1751.13 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 438.71 | 330.05 | 510.27 | 121.86 | 175.67 |
| Inventories | 903.85 | 828.36 | 815.63 | 791.07 | 766.47 |
| Trade Receivables | 1182.74 | 1246.84 | 1056.90 | 1019.81 | 738.43 |
| Cash And Cash Equivalents | 176.24 | 130.77 | 330.90 | 211.79 | 209.61 |
| Short Term Loans And Advances | 2.54 | 33.96 | 17.39 | 6.37 | 8.03 |
| OtherCurrentAssets | 138.95 | 160.94 | 102.91 | 113.56 | 129.38 |
| Total Current Assets | 2843.03 | 2730.92 | 2834.00 | 2264.46 | 2027.59 |
| | | | | | |
| Total Assets | 5014.95 | 4638.39 | 4679.02 | 4055.58 | 3778.72 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 161.39 | 91.52 | 76.44 | 168.98 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 0.00 | 15.63 | 15.63 | 7.09 | 7.09 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Unquoted Book Value | 0.00 | 18.58 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| CURRENT INVESTMENTS | | | | | |
| Current Investments Quoted Market Value | 0.00 | 299.15 | 510.27 | 121.86 | 138.99 |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 36.68 |
